Cargando…

The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030

BACKGROUND: Leukemia is a common malignancy that has four main subtypes and is a threat to human health. Understanding the epidemiological status of leukemia and its four main subtypes globally is important for allocating appropriate resources, guiding clinical practice, and furthering scientific re...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Mengbao, Chen, Weiwei, Liu, Ke, Wang, Limengmeng, Hu, Yihan, Mao, Yingying, Sun, Xiaohui, Luo, Yi, Shi, Jimin, Shao, Keding, Huang, He, Ye, Ding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061017/
https://www.ncbi.nlm.nih.gov/pubmed/35509847
http://dx.doi.org/10.1155/2022/1612702
_version_ 1784698634262020096
author Du, Mengbao
Chen, Weiwei
Liu, Ke
Wang, Limengmeng
Hu, Yihan
Mao, Yingying
Sun, Xiaohui
Luo, Yi
Shi, Jimin
Shao, Keding
Huang, He
Ye, Ding
author_facet Du, Mengbao
Chen, Weiwei
Liu, Ke
Wang, Limengmeng
Hu, Yihan
Mao, Yingying
Sun, Xiaohui
Luo, Yi
Shi, Jimin
Shao, Keding
Huang, He
Ye, Ding
author_sort Du, Mengbao
collection PubMed
description BACKGROUND: Leukemia is a common malignancy that has four main subtypes and is a threat to human health. Understanding the epidemiological status of leukemia and its four main subtypes globally is important for allocating appropriate resources, guiding clinical practice, and furthering scientific research. METHODS: Average annual percentage changes (AAPCs) were calculated to estimate the change trends of age-standardized rates (ASRs) from 1990 to 2019 in 204 countries and territories. The risk factors for leukemia death and disability-adjusted life-year (DALY) were also analyzed. In addition, the future trends in ASRs were projected through 2030. RESULTS: The total number of incident cases, deaths, and DALYs from leukemia in 2019 was 0.64, 0.33, and 11.66 million, respectively. Decreasing trends in age-standardized incidence rate (ASIR), the age-standardized death rate (ASDR), and age-standardized DALY rate were detected on a global level while increasing trends in ASIR were detected in the high-sociodemographic index (SDI) regions. The leukemia burden was heavier in males than in females. By cause, acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL) were more likely to impose a burden on the elderly, while acute lymphoblastic leukemia (ALL) showed a greater impact in the younger population. A significant positive correlation was observed between SDI and AAPC in ASIR, while SDI was negatively correlated with AAPCs in both ASDR and age-standardized DALY rate. Smoking remained the most significant risk factor associated with leukemia-related death and DALY, especially in males. Similar deaths and DALYs were caused by smoking and high body mass index (BMI) in females. Future projections through 2030 estimated that ASIR and ASDR will continue to increase, while the DALY rate is predicted to decline. CONCLUSIONS: Patterns and trends of leukemia burden are correlated with SDI. The estimated contributions to leukemia deaths indicate that timely measures are needed to reduce smoking and obesity.
format Online
Article
Text
id pubmed-9061017
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90610172022-05-03 The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030 Du, Mengbao Chen, Weiwei Liu, Ke Wang, Limengmeng Hu, Yihan Mao, Yingying Sun, Xiaohui Luo, Yi Shi, Jimin Shao, Keding Huang, He Ye, Ding J Oncol Research Article BACKGROUND: Leukemia is a common malignancy that has four main subtypes and is a threat to human health. Understanding the epidemiological status of leukemia and its four main subtypes globally is important for allocating appropriate resources, guiding clinical practice, and furthering scientific research. METHODS: Average annual percentage changes (AAPCs) were calculated to estimate the change trends of age-standardized rates (ASRs) from 1990 to 2019 in 204 countries and territories. The risk factors for leukemia death and disability-adjusted life-year (DALY) were also analyzed. In addition, the future trends in ASRs were projected through 2030. RESULTS: The total number of incident cases, deaths, and DALYs from leukemia in 2019 was 0.64, 0.33, and 11.66 million, respectively. Decreasing trends in age-standardized incidence rate (ASIR), the age-standardized death rate (ASDR), and age-standardized DALY rate were detected on a global level while increasing trends in ASIR were detected in the high-sociodemographic index (SDI) regions. The leukemia burden was heavier in males than in females. By cause, acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL) were more likely to impose a burden on the elderly, while acute lymphoblastic leukemia (ALL) showed a greater impact in the younger population. A significant positive correlation was observed between SDI and AAPC in ASIR, while SDI was negatively correlated with AAPCs in both ASDR and age-standardized DALY rate. Smoking remained the most significant risk factor associated with leukemia-related death and DALY, especially in males. Similar deaths and DALYs were caused by smoking and high body mass index (BMI) in females. Future projections through 2030 estimated that ASIR and ASDR will continue to increase, while the DALY rate is predicted to decline. CONCLUSIONS: Patterns and trends of leukemia burden are correlated with SDI. The estimated contributions to leukemia deaths indicate that timely measures are needed to reduce smoking and obesity. Hindawi 2022-04-25 /pmc/articles/PMC9061017/ /pubmed/35509847 http://dx.doi.org/10.1155/2022/1612702 Text en Copyright © 2022 Mengbao Du et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Du, Mengbao
Chen, Weiwei
Liu, Ke
Wang, Limengmeng
Hu, Yihan
Mao, Yingying
Sun, Xiaohui
Luo, Yi
Shi, Jimin
Shao, Keding
Huang, He
Ye, Ding
The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030
title The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030
title_full The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030
title_fullStr The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030
title_full_unstemmed The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030
title_short The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030
title_sort global burden of leukemia and its attributable factors in 204 countries and territories: findings from the global burden of disease 2019 study and projections to 2030
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061017/
https://www.ncbi.nlm.nih.gov/pubmed/35509847
http://dx.doi.org/10.1155/2022/1612702
work_keys_str_mv AT dumengbao theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT chenweiwei theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT liuke theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT wanglimengmeng theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT huyihan theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT maoyingying theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT sunxiaohui theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT luoyi theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT shijimin theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT shaokeding theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT huanghe theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT yeding theglobalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT dumengbao globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT chenweiwei globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT liuke globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT wanglimengmeng globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT huyihan globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT maoyingying globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT sunxiaohui globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT luoyi globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT shijimin globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT shaokeding globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT huanghe globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030
AT yeding globalburdenofleukemiaanditsattributablefactorsin204countriesandterritoriesfindingsfromtheglobalburdenofdisease2019studyandprojectionsto2030